908 Devices (MASS) Non-Current Deffered Revenue (2020 - 2026)
908 Devices' (MASS) quarterly Non-Current Deffered Revenue came in at $9.1 million in Q1 2026, down 5.0% year-on-year from $9.5 million in Q1 2025, and up 8.85% on a QoQ basis from $8.3 million in Q4 2025.
908 Devices (MASS) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Non-Current Deffered Revenue data on file, last reported at $9.1 million in Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue fell 5.0% year-over-year to $9.1 million in Q1 2026; TTM through Mar 2026 was $9.1 million, a 5.0% decrease from a year earlier, with the FY2025 full-year figure at $8.3 million, down 18.43% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $9.1 million, up from $8.3 million in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for MASS reached as high as $12.2 million in Q3 2022 and fell as low as $7.9 million in Q1 2024.
- Historically, Non-Current Deffered Revenue has averaged $9.9 million across 5 years, with a median of $9.5 million in 2024.
- Across the five-year window, Non-Current Deffered Revenue jumped 41.27% in 2022 and dropped 27.72% in 2024, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $11.5 million in 2022, then slipped by 25.44% to $8.6 million in 2023, then gained by 19.16% to $10.2 million in 2024, then declined by 18.43% to $8.3 million in 2025, then rose by 8.85% to $9.1 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $9.1 million in Q1 2026, $8.3 million in Q4 2025, and $9.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 512.79 Mn |
| 10 | 908 Devices | 264.17 Mn | 152.43 Mn | 6.88 Mn | 9.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.07 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 9.19 Mn |
| Jun 30, 2025 | 9.18 Mn |
| Mar 31, 2025 | 9.55 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Sep 30, 2024 | 11.03 Mn |
| Jun 30, 2024 | 9.53 Mn |
| Mar 31, 2024 | 7.87 Mn |
| Dec 31, 2023 | 8.57 Mn |
| Sep 30, 2023 | 9.37 Mn |
| Jun 30, 2023 | 8.47 Mn |
| Mar 31, 2023 | 10.89 Mn |
| Dec 31, 2022 | 11.50 Mn |
| Sep 30, 2022 | 12.16 Mn |
| Jun 30, 2022 | 11.65 Mn |
| Mar 31, 2022 | 11.60 Mn |
| Dec 31, 2021 | 11.96 Mn |
| Sep 30, 2021 | 10.41 Mn |
| Jun 30, 2021 | 8.25 Mn |